Phenprocoumon

Phenprocoumon
Clinical data
Trade names	Marcoumar, Marcumar, Falithrom
AHFS/Drugs.com	International Drug Names
MedlinePlus	a699003
ATC code	B01AA04 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Protein binding	99%
Metabolism	hepatic to inactive metabolites
Elimination half-life	5 to 6 days
Identifiers
	IUPAC name (RS)-4-hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one;
CAS Number	435-97-2 ;
PubChem CID	9908;
IUPHAR/BPS	6839;
DrugBank	DB00946 ;
ChemSpider	10441592 ;
UNII	Q08SIO485D;
KEGG	D05457 ;
ChEBI	CHEBI:50438 ;
ChEMBL	CHEMBL1465 ;
ECHA InfoCard	100.006.464
Chemical and physical data
Formula	C18H16O3
Molar mass	280.318 g/mol
3D model (JSmol)	Interactive image;
	SMILES OC=1c3ccccc3OC(=O)C=1C(CC)c2ccccc2;
	InChI InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3 ; Key:DQDAYGNAKTZFIW-UHFFFAOYSA-N ;
(verify)

Phenprocoumon (marketed under the brand names Marcoumar, Marcumar and Falithrom) is a long-acting oral anticoagulant drug, a derivative of coumarin. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism). It is the standard coumarin used in Germany.

Phenprocoumon is a 4-hydroxycoumarin and inhibits vitamin K epoxide reductase.^[1]

References

↑ Phenprocoumon at PharmGKB

External links

DDB 29943

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Phenprocoumon at PharmGKB